Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
92.33
+0.82 (0.90%)
Mar 13, 2025, 4:00 PM EST - Market closed
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | 12.45B | 12.34B | 12.16B | 12.00B | 11.47B | 11.32B | 11.11B | - | 11.22B | ||||||||
| Cardiovascular Growth | 8.49% | 9.03% | 9.48% | 7.00% | 2.52% | 0.64% | -2.76% | - | -1.33% | ||||||||
| Neuroscience | 9.64B | 9.53B | 9.37B | 9.27B | 9.11B | 8.94B | 8.77B | - | 8.85B | ||||||||
| Neuroscience Growth | 5.77% | 6.62% | 6.87% | 4.79% | 4.19% | 2.84% | -0.17% | - | 0.79% | ||||||||
| Medical Surgery | 8.32B | 8.40B | 8.41B | 8.45B | 8.47B | 8.39B | 8.25B | - | 8.44B | ||||||||
| Medical Surgery Growth | -1.72% | 0.10% | 1.98% | 0.17% | -1.47% | -4.91% | -9.79% | - | -8.76% | ||||||||
| Diabetes | 2.62B | 2.57B | 2.49B | 2.42B | 2.40B | 2.31B | 2.25B | - | 2.26B | ||||||||
| Diabetes Growth | 9.34% | 10.98% | 11.00% | 7.02% | 5.27% | 0.30% | -3.98% | - | -5.19% |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Apr 28, 2023 | Jan 27, 2023 | Oct 28, 2022 | Jul 29, 2022 | Apr 29, 2022 | Jan 28, 2022 | Oct 29, 2021 | Jul 30, 2021 | Apr 30, 2021 | Jan 29, 2021 | Oct 30, 2020 | Jul 31, 2020 | Apr 24, 2020 | Jan 24, 2020 | Oct 25, 2019 | Jul 26, 2019 | Apr 26, 2019 | Jan 25, 2019 | Oct 26, 2018 | Jul 27, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| US | 16.97B | 16.85B | 16.72B | 16.56B | 16.70B | 16.64B | 16.53B | 16.37B | |||||||||||||||||||
| US Growth | 1.62% | 1.27% | 1.14% | 1.15% | 4.38% | 4.83% | 4.63% | 1.48% | |||||||||||||||||||
| Rest of World | 16.23B | 16.15B | 15.86B | 15.80B | 15.62B | 15.32B | 15.03B | 14.85B | |||||||||||||||||||
| Rest of World Growth | 3.90% | 5.40% | 5.52% | 6.38% | 5.72% | 2.56% | -1.60% | -4.49% |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative | 10.89B | 10.85B | 10.78B | 10.74B | 10.59B | 10.53B | 10.46B |
| Selling, General, and Administrative Growth | 2.89% | 3.04% | 3.04% | 3.09% | 2.12% | 2.09% | 1.44% |
| Research and Development | 2.72B | 2.74B | 2.74B | 2.74B | 2.70B | 2.69B | 2.67B |
| Research and Development Growth | 0.81% | 1.82% | 2.69% | 1.48% | -0.26% | 0.22% | -0.60% |
| Amortization | 1.66B | 1.67B | 1.68B | 1.69B | 1.70B | 1.71B | 1.70B |
| Amortization Growth | -2.00% | -2.52% | -1.58% | -0.35% | -0.82% | -0.18% | -0.99% |
| Other Expenses | 439.00M | 461.00M | 464.00M | 464.00M | 43.00M | -99.00M | -165.00M |
| Other Expenses Growth | 920.93% | - | - | - | - | - | - |
| Restructuring | 232.00M | 209.00M | 219.00M | 226.00M | 408.00M | 426.00M | 416.00M |
| Restructuring Growth | -43.14% | -50.94% | -47.36% | -39.89% | 270.91% | 407.14% | 550.00% |
| Litigation | 147.00M | - | 190.00M | 149.00M | - | 75.00M | 10.00M |
| Litigation Growth | - | - | 1,800.00% | - | - | - | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.